A Study to Evaluate the Effect of Single Oral Dose of Balinatunfib on Cardiac Repolarization in Healthy Adult Participants.

Recruiting

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(2 sites)

United States

FORTREA CLINICAL RESEARCH UNIT INC- Site Number : 8400002, Dallas, Texas

FORTREA CLINICAL RESEARCH UNIT INC- Site Number : 8400001, Madison, Wisconsin